Australia is well positioned to be a leading destination for early phase clinical trials – currently commencing over 1000 new trials each year. But how can we further capitalise on this opportunity?
Bio Connections Australia is an annual, national event designed to foster the growth of early phase clinical research in Australia.
As a unique platform for networking and discussion, this comprehensive, two-day conference focuses on drug discovery, early phase clinical trials, translational research, and expediting Australia’s great science into commercialisation.
Bringing together a mix of the nation’s industry executives, researchers, and academics, the event is also attended by international pharmaceutical and biotechnology companies looking to conduct clinical trial activity in Australia.
Key topics for discussion include:
- The opportunities and obstacles to early phase clinical trials in Australia vs International
- Aussie biotech success stories & the path to commercial success
- Optimising drug development in Australia
- Global best practice tools & techniques for designing a clinical development programme
- Leveraging Emerging Technologies Including Machine Learning & Deep Sequencing for Clinical Development
- Medical device trials in Australia
- Assessing partnerships in clinical trials
- Translational research and expediting research into commercialization
- Models for turning discovery into drugs
- Finding the funding – navigating challenges and getting ahead of the pack
- Government incentives for biotech, pharma and medtech companies in Australia
- Recruitment and engagement in clinical trials across Australia
- Mitigating risk and ensuring patient safety
- Australia as a springboard into Asia – regional partnership opportunities
- The regulatory environment in Australia & comparing international regulatory pathways
- Governance, bureaucracy, ethics: How we cultivate innovation rather than stifling it
- Driving greater collaboration across academia and industry
Dr Thomas Oxley
CEO and Founder, Synchron
2019 VIC Australian of the Year and Managing Director, Medicines Development for Global Health